Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

TSMC is mulling setting up more fabs overseas, apart from its exsiting facility in Nanjing, China and the one being built in the US. TSMC is looking at building new fabs in Japan and Germany for 28nm and 12/16nm chip output. Apple is keen on adopting miniLED backlighting for its devices, and is likely to add China-based Luxshare as a second supplier of SMT services for miniLED BLUs. Meanwhile, notebook component suppliers are turning cautious about building up inventory amid mixed signals about the notebook market’s outlook.

TSMC mulls 28nm, 12/16nm process capacity expansion overseas: TSMC will soon disclose plans to build additional 28nm and 12/16nm process fabrication lines at new fabs, in addition to its Nanjing fab expansion, according to industry sources.

Luxshare to become second SMT service provider for miniLED backlighting for Apple: Taiwan Surface Mounting Technology (SMT) is currently the only provider of SMT services for Apple’s miniLED backlighting applications, but China-based Luxshare Precision Industry is expected to become a second provider in fourth-quarter 2021 at the earliest, according to industry sources.

Read more | >

When thinking of the crypto community, or any other movement for that matter, it’s common to think of where it is now. Hundreds of projects, thousands of developers, millions of users. But crypto started, not so long ago, with a nobody, Satoshi Nakamoto.

By building a small, but incredibly dedicated community of supporters, crypto has become an unstoppable force which will define this century, changing the core of our economic system: money itself.

At Superfluid, we are incredibly excited to be a part of this monumental shift, contributing our own innovation to magical internet money: modular asset streaming.

Read more | >

When we think about singularities, we tend to think of massive black holes in faraway galaxies or a distant future with runaway AI, but singularities are all around us. Singularities are simply a place where certain parameters are undefined. The North and South Pole, for example, are what’s known as coordinate singularities because they don’t have a defined longitude.

Optical singularities typically occur when the phase of with a specific wavelength, or color, is undefined. These regions appear completely dark. Today, some optical singularities, including optical vortices, are being explored for use in optical communications and particle manipulation but scientists are just beginning to understand the potential of these systems. The question remains—can we harness darkness like we harnessed light to build powerful, new technologies?

Now, researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a new way to control and optical singularities. The technique can be used to engineer singularities of many shapes, far beyond simple curved or straight lines. To demonstrate their technique, the researchers created a singularity sheet in the shape of a heart.

Read more | >

After Sir Richard Branson’s spaceflight this weekend, the leader of Russia’s main space corporation, Roscosmos, offered some kind words about the achievement on Twitter. Dmitry Rogozin called the flight a “landmark” in terms of technology development and expanding the number of humans able to see Earth from space.

Then Rogozin went a step further, lamenting the fact that Russia’s “billionaire oligarchs” spend their money on yachts and vanity projects rather than the development of space technology and increasing humanity’s knowledge of space.

This is a notable comment from Rogozin, who in the past has been critical of one particular billionaire spending his money developing space technology: SpaceX founder Elon Musk. Among other remarks, Rogozin has said that NASA should not get too cocky about its newfound access to space in case SpaceX’s Crew Dragon vehicle “breaks.” He has also said that SpaceX is “gentle” for getting to work in the balmy conditions of South Texas, while Russian engineers and technicians work in the depths of Siberia during the winter.

Read more | >

The U.S. military says it is months away from launching clinical trials of a pill designed to block or reduce many degenerative effects of aging—an oral treatment that a leading researcher in the field says is better than nothing while questioning how effective it will ultimately prove.

U.S. Special Operations Command (SOCOM)—which develops and employs Special Operations Forces worldwide to advance U.S. policies and objectives—has “completed preclinical safety and dosing studies in anticipation of follow-on performance testing” of a first-in-class nicotinamide adenine dinucleotide, oxidized state (NAD+) enhancer, a small molecule drug being developed by Metro International Biotech (MetroBiotech), Navy Cmdr. Timothy A. Hawkins, a spokesperson for SOCOM, told GEN.

SOCOM and MetroBiotech are set to start clinical trials during the 2022 federal fiscal year, which starts October 1.

Read more | >